ENTRY       D04008                      Drug
NAME        Entecavir (USP);
            Entecavir hydrate (JAN);
            Baraclude (TN)
PRODUCT     BARACLUDE (E.R. Squibb & Sons)
  GENERIC   ENTECAVIR (Accord Healthcare)
            ENTECAVIR (American Health Packaging)
            ENTECAVIR (Amneal Pharmaceuticals LLC)
            ENTECAVIR (Aurobindo Pharma Limited)
            ENTECAVIR (AvKARE)
            ENTECAVIR (AvPAK)
            ENTECAVIR (Breckenridge Pharmaceutical)
            ENTECAVIR (Camber Pharmaceuticals)
            ENTECAVIR (Cipla USA)
            ENTECAVIR (EPIC PHARMA)
            ENTECAVIR (Florida Pharmaceutical Products)
            ENTECAVIR (NorthStar RxLLC)
            ENTECAVIR (Solco Healthcare LLC)
            ENTECAVIR (YUNG SHIN PHARM. IND.)
            ENTECAVIR (Yaopharma)
            ENTECAVIR (Zydus Lifesciences Limited)
            ENTECAVIR (Zydus Pharmaceuticals USA)
FORMULA     C12H15N5O3. H2O
EXACT_MASS  295.1281
MOL_WEIGHT  295.2945
CLASS       Antiviral
             DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
REMARK      Therapeutic category: 6250
            ATC code: J05AF10
            Chemical structure group: DG00661
            Product (DG00661): D04008<JP/US>
EFFICACY    Antiviral, Reverse transcriptase inhibitor
  DISEASE   Hepatitis B [DS:H00412]
TARGET      HBV reverse transcriptase [KO:K21037]
  PATHWAY   ko03230(K21037)  Viral genome structure
            ko03240(K21037)  Viral replication
            ko05161(K21037)  Hepatitis B
STR_MAP     map07044  Antiviral agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
                 J05AF10 Entecavir
                  D04008  Entecavir (USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-hepatitis B (HBV) Agents
               Entecavir
                D04008  Entecavir (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D04008  Entecavir (USP); Entecavir hydrate (JAN)
            Drug groups [BR:br08330]
             Antiviral
              DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
               DG00661  Entecavir
                D04008  Entecavir
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HBV reverse transcriptase inhibitor
                D04008  Entecavir (USP) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D04008
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D04008
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D04008
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D04008
            Drug groups [BR:br08330]
             Antiviral
              DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
               DG00661  Entecavir
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Genome replication inhibitor
               HBV reverse transcriptase inhibitor
                DG00661  Entecavir
DBLINKS     CAS: 209216-23-9
            PubChem: 17398002
            ChEBI: 59902
            LigandBox: D04008
ATOM        21
            1   O0  O    30.7234  -17.2838
            2   C8y C    23.0300  -15.3300
            3   C8y C    23.0300  -16.8000
            4   C8y C    24.0100  -14.6300
            5   N5x N    21.7000  -14.9800
            6   N4y N    21.7700  -17.2900
            7   N5x N    24.2200  -17.4300
            8   O5x O    24.0100  -13.2300
            9   N4x N    25.3400  -15.1900
            10  C8x C    20.8600  -16.1700
            11  C1y C    20.1600  -18.4100
            12  C8y C    25.3400  -16.7300
            13  C2y C    19.0400  -17.5700
            14  C1x C    19.6700  -19.6000
            15  N1a N    26.6000  -17.2900
            16  C1y C    17.9200  -18.2700
            17  C1y C    18.3400  -19.6000
            18  C1b C    16.6600  -17.8500
            19  O1a O    15.6100  -18.6900
            20  C2a C    19.0400  -16.1700
            21  O1a O    17.5000  -20.7200
BOND        22
            1     2   3 2
            2     2   4 1
            3     2   5 1
            4     3   6 1
            5     3   7 1
            6     4   8 2
            7     4   9 1
            8     5  10 2
            9    11   6 1 #Up
            10    7  12 2
            11   11  13 1
            12   11  14 1
            13   12  15 1
            14   13  16 1
            15   14  17 1
            16   16  18 1 #Up
            17   18  19 1
            18    6  10 1
            19    9  12 1
            20   16  17 1
            21   13  20 2
            22   17  21 1 #Down
///
